R475 + Placebo
Phase 2Withdrawn 0 views this week 0 watching💤 Quiet
Interest: 27/100
27
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Thermal Injury Pain
Conditions
Thermal Injury Pain
Trial Timeline
— → —
NCT ID
NCT01053702About R475 + Placebo
R475 + Placebo is a phase 2 stage product being developed by Sanofi for Thermal Injury Pain. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT01053702. Target conditions include Thermal Injury Pain.
What happened to similar drugs?
0 of 2 similar drugs in Thermal Injury Pain were approved
Approved (0) Terminated (0) Active (2)
Hype Score Breakdown
Clinical
12
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01053702 | Phase 2 | Withdrawn |
Competing Products
4 competing products in Thermal Injury Pain
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| cP12 | United Therapeutics | Phase 2 | 39 |
| NexoBrid | MediWound | Pre-clinical | 16 |
| NexoBrid + Gel Vehicle | MediWound | Phase 3 | 30 |
| NexoBrid | MediWound | Phase 3 | 30 |